uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Forgotten antibiotics: a follow-up inventory study in Europe, the USA, Canada and Australia
Univ Lorraine, Ctr Hosp Reg Univ CHRU Nancy, Fac Med, Serv Malad Infect & Trop, Rue Morvan, F-54511 Nancy, France..
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Infectious Diseases.
Univ Med Ctr Ljubljana, Ljubljana, Slovenia..
Radboud Univ Nijmegen, Med Ctr, Dept Med, Nijmegen, Netherlands.;Canisius Wilhelmina Hosp, Dept Med Microbiol & Infect Dis, Nijmegen, Netherlands.;Hasselt Univ, Hasselt, Belgium..
Show others and affiliations
2017 (English)In: International Journal of Antimicrobial Agents, ISSN 0924-8579, E-ISSN 1872-7913, Vol. 49, no 1, 98-101 p.Article in journal (Refereed) Published
Abstract [en]

The objective of this study was to update a 2011 survey, conducted on behalf of the ESCMID Study Group for Antibiotic Policies (ESGAP), studying the availability of old but clinically useful antibiotics in North America, Europe and Australia. This follow-up survey was performed in 2015 in 40 countries among specialists from the pharmaceutical, infectious diseases and microbiology sectors in North America, Europe and Australia in order to assess the availability through usual marketing processes of 36 systemic antibiotics (addition of 3 antibiotics compared with the 2011 survey) selected for their ability to treat infections caused by resistant bacteria and their unique value for specific criteria. The questionnaire was sent by e-mail to national contacts belonging to ESGAP and ReAct networks. In all, 39 of the 40 countries participated in this survey. The number of available antibiotics differed considerably from one drug to another as well as from one country to another (e.g. 7 antibiotics available in Estonia, 24 in France). Overall, 25/36 selected antibiotics were marketed in 20/39 countries or less. From 2011 to 2015 (data available for both periods in 37 countries for 33 antibiotics), the number of available selected antibiotics increased in 13 countries and decreased in 17. In conclusion, despite the ongoing bacterial resistance crisis, the situation regarding the availability of 'forgotten antibiotics' has worsened since 2011. Urgent measures are needed to ensure better availability of these antibiotics on a global scale as a conservation measure to ensure sustainable and responsible use of antibiotics. (C) 2016 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.

Place, publisher, year, edition, pages
ELSEVIER SCIENCE BV , 2017. Vol. 49, no 1, 98-101 p.
Keyword [en]
Bacterial resistance, Drug approval, Drug marketing, Antibiotic stewardship
National Category
Infectious Medicine
Identifiers
URN: urn:nbn:se:uu:diva-319293DOI: 10.1016/j.ijantimicag.2016.09.029ISI: 000396429300014PubMedID: 27887966OAI: oai:DiVA.org:uu-319293DiVA: diva2:1088173
Available from: 2017-04-11 Created: 2017-04-11 Last updated: 2017-04-11Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Cars, Otto
By organisation
Infectious Diseases
In the same journal
International Journal of Antimicrobial Agents
Infectious Medicine

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 129 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf